States / Minnesota / HF 4852

HF 4852 In Committee

Formulary Committee members with a potential conflict of interest permitted to participate in committee communications and discussions, commissioner of human services required to develop a public comment process for recommendations, and committee required to seek expertise from the Minnesota Rare Disease Advisory Council.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Introduction Apr 6, 2026 · 3.8K words Open full page ↗

Skip to main content

Skip to footer

Minnesota Legislature

Advanced

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.